2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$14.72+$0.14 (+0.96%)
Price as of Oct 02, 2026 4:36 PM EDT- $5.1BMarket Cap
- 584.51%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$14.72+$0.14 (+0.96%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.58 | ||
Change | -$0.08 (-0.55%) | ||
Open | $14.66 | ||
High | $15.01 | ||
Low | $14.33 | ||
Previous Close | $14.66 | ||
Volume | 3,691,662 | ||
30-Day Average Volume | 4,774,678 | ||
1-Week Change | 0.41% | ||
1-Month Change | -13.01% | ||
1-Year Change | 584.51% | ||
3-Year Change | 640.10% | ||
5-Year Change | -32.37% | ||
Fundamentals | |||
Shares Outstanding | 349.8M | ||
Total Assets | $435.1M | ||
Market Cap | $5.1B | ||
Enterprise Value | $5.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$44.1M | ||
Free Cash Flow | -$27.3M | ||
EBIT | -$44.1M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $244.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -117 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -104 | ||
PEG | -1 | ||
Price/Free Cash Flow | -187 | ||
Price/Operating Cash Flow | -187 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue